Form 4 for GH Guardant Health, Inc.
Accepted 2021-07-01 00:00:00 ET · period of report 2021-06-29 · accession 0001576280-21-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-01 | 2021-06-29 | GH | CLARK IAN T | Dir | S - Sale+OE | $130.00 | -10.6K | 0 | -100% | -$1.37M |
| DM | 2021-07-01 | 2021-06-29 | GH | CLARK IAN T | Dir | M - OptEx | $63.83 | +5,916 | 5,719 | New | +$377.6K |
| DM | 2021-07-01 | 2021-06-29 | GH | CLARK IAN T | Dir | M - OptEx | $0.00 | -5,916 | 2,152 | -73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-06-29 | S | D | 10,559 | $130.00 | 0 | D | — | — | (F1) These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| 2 | Common | COMMON STOCK | 2021-06-29 | M | A | 4,840 | $77.09 | 10,559 | D | — | — | |
| 3 | Common | COMMON STOCK | 2021-06-29 | M | A | 1,076 | $4.18 | 5,719 | D | — | — | |
| 4 | Derivative | STOCK OPTION (RIGHT TO BUY) | 2021-06-29 | M | D | 4,840 | $0.00 | 0 | D | $77.09 · — to 2030-06-11 | 4,840 COMMON STOCK | (F3) The stock option vests in full on the earlier to occur of (i) June 12, 2021 and (ii) the date of the next annual meeting of the Issuer's stockholders. |
| 5 | Derivative | STOCK OPTION (RIGHT TO BUY) | 2021-06-29 | M | D | 1,076 | $0.00 | 2,152 | D | $4.18 · — to 2027-11-29 | 1,076 COMMON STOCK | (F2) The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on October 25, 2017. |